On Christmas Day, billionaire Elon Musk shocked his followers by sharing a revealing post about his weight-loss journey. Known for his outspoken personality, Musk posted a photo of himself dressed as Santa Claus on X, formerly known as Twitter, with the caption “Ozempic Santa.” He then clarified in the replies that while the drug he’s taking is technically Mounjaro, not Ozempic, he chose the more familiar name for its ring.
Musk's Christmas Post and the Secret Behind His Weight Loss
Musk’s candidness about using medication to shed pounds left many of his followers surprised, as he has always been an advocate for pushing boundaries, both in business and personal health. The post showed the Tesla and SpaceX CEO in a classic red-and-white Santa costume, accompanied by the playful phrase "Ozempic Santa." While the internet quickly buzzed about the medication’s popularity among celebrities, Musk clarified that he was actually using Mounjaro, a drug related to Ozempic, for weight loss.
Ozempic and Mounjaro are both injectable medications originally designed to treat type-2 diabetes. They have gained significant attention as anti-obesity treatments due to their ability to help individuals lose weight when combined with diet and exercise. Mounjaro, which contains the active ingredient tirzepatide, was approved by the U.S. Food and Drug Administration (FDA) in 2022 and has become a common choice for those struggling with obesity-related health issues such as high blood pressure, high cholesterol, and sleep apnea.
Mounjaro vs. Ozempic: How They Work and Their Growing Popularity
Both Ozempic and Mounjaro work by regulating insulin levels and suppressing appetite. The drugs have been lauded for their effectiveness in weight loss, with many people using them to shed significant amounts of weight. Mounjaro is considered more powerful than Ozempic due to its unique combination of drugs, but both are widely regarded as effective in the treatment of obesity and related conditions.
Musk’s admission comes after he had previously shared that he lost 30 pounds by combining fasting with Ozempic/Wegovy, another brand of the same active ingredient, semaglutide. The revelation has sparked widespread discussion on social media about the ethics and long-term effectiveness of using prescription medications for weight loss. Musk’s fans have embraced his transparency, but others have raised concerns about the potential risks of using these drugs for non-medical reasons.
Public Reaction to Musk's Post on X
The reaction to Musk’s post has been swift and divided. While some praised Musk for his honesty, others expressed skepticism. Many social media users found it amusing that Musk, who is known for his eccentric behavior, would embrace the “Ozempic Santa” persona. However, others questioned the influence of such posts, particularly when they involve prescription drugs that are not typically intended for widespread, casual use.
Here’s what some Twitter users had to say:
- @TechGuru2024: “Elon Musk’s Ozempic confession is not surprising, but it's funny to see him embrace the Santa look. #OzempicSanta”
- @HealthyLiving123: “Musk using Ozempic to lose weight? Must be nice to have access to these treatments. #Mounjaro #WeightLoss”
- @TheRealChrisJ: “I love how Musk is always willing to share his secrets, even the ones that might raise some eyebrows.”
- @GadgetsAndGains: “Do people realize how dangerous it can be to promote these meds for weight loss without medical supervision? #OzempicSanta”
- @MindYourBusiness21: “Elon Musk and Mounjaro, now that’s an unexpected combo. #BusinessAndHealth”
- @FuturiTechFan: “Musk’s transparency about his weight-loss methods is refreshing, but it’ll definitely stir the pot. #OzempicSanta”
What's Next for Musk and His Health Journey?
Musk’s weight-loss journey is far from over. As he continues to make headlines with his personal and professional endeavors, including his involvement in the newly created Department of Government Efficiency (DOGE), it remains to be seen how his decision to openly embrace weight-loss treatments will affect his public image. In the meantime, Musk’s followers can expect more surprises as he prepares for a major role in the upcoming administration and his next business ventures.


Trump Administration Moves to Keep TransAlta Coal Plant Running Amid Rising AI Power Demand
Sydney Bondi Beach Terror Attack Kills 16, Sparks Gun Law and Security Debate
Zelenskiy Signals Willingness to Drop NATO Bid as Ukraine, U.S. Hold Crucial Peace Talks in Berlin
Pakistan’s Army Chief Faces Gaza Troop Dilemma Amid US Pressure
U.S. Suspends UK Technology Deal Amid Trade Disputes Under Trump Administration
U.S. Offers NATO-Style Security Guarantees to Ukraine as Peace Talks Show Progress
Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law
Trump Taps Former DHS Official Troy Edgar for U.S. Ambassador Role in El Salvador
Jimmy Lai Convicted Under Hong Kong National Security Law in Landmark Case
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Lukashenko Says Maduro Welcome in Belarus Amid Rising U.S.-Venezuela Tensions
Trump Weighs Reclassifying Marijuana as Schedule III, Potentially Transforming U.S. Cannabis Industry
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Belarus Frees Opposition Leaders Maria Kalesnikava and Viktar Babaryka in U.S.-Brokered Deal
European Leaders Tie Ukraine Territorial Decisions to Strong Security Guarantees
European Leaders Launch International Claims Commission to Compensate Ukraine for War Damage 



